TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs11180559
log Bayes Factor = 0.335449
Chromosome 12   position 75,920,285  (GRCh37) Explore rs11180559 on Ensembl!
Variant rs11180559 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.440 0.560
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.445 0.555
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.452 0.548
T43.2 Other and unspecified antidepressants
0.000 0.463 0.537
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.488 0.512
T39.1 4-Aminophenol derivatives
0.000 0.491 0.509
T39.0 Salicylates
0.000 0.498 0.502
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.502 0.498
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.511 0.489
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.524 0.476
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.534 0.466
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.538 0.462
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.546 0.454
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.547 0.453
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.553 0.447
T36 Poisoning by systemic antibiotics
0.000 0.554 0.446
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.557 0.443
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.559 0.441
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.579 0.420
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.588 0.412
T43.6 Psychostimulants with abuse potential
0.000 0.591 0.409
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.599 0.401
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.599 0.401
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.599 0.401
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.599 0.401
T43.9 Psychotropic drug, unspecified
0.000 0.602 0.398
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.602 0.398
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.602 0.398
T39.4 Antirheumatics, not elsewhere classified
0.000 0.607 0.393
T39.2 Pyrazolone derivatives
0.000 0.607 0.393
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.608 0.392
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.617 0.383
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.618 0.382
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.625 0.375
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.626 0.374
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.633 0.367
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.633 0.367
T46.7 Peripheral vasodilators
0.000 0.633 0.367
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.633 0.367
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.633 0.367
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.633 0.367
T46.1 Calcium-channel blockers
0.000 0.633 0.367
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.633 0.367
T36.0 Penicillins
0.000 0.636 0.364
T50.8 Diagnostic agents
0.000 0.643 0.357
T50.7 Analeptics and opioid receptor antagonists
0.000 0.643 0.357
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.643 0.357
T50.5 Appetite depressants
0.000 0.643 0.357
T50.4 Drugs affecting uric acid metabolism
0.000 0.643 0.357
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.643 0.357
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.643 0.357
T50.1 Loop [high-ceiling] diuretics
0.000 0.643 0.357
T50.0 Mineralocorticoids and their antagonists
0.000 0.643 0.357
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.645 0.355
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.652 0.347
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.668 0.332
T38.9 Other and unspecified hormone antagonists
0.000 0.669 0.331
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.669 0.331
T38.7 Androgens and anabolic congeners
0.000 0.669 0.331
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.669 0.331
T38.5 Other oestrogens and progestogens
0.000 0.669 0.331
T38.4 Oral contraceptives
0.000 0.669 0.331
T38.2 Antithyroid drugs
0.000 0.669 0.331
T38.1 Thyroid hormones and substitutes
0.000 0.669 0.331
T38.0 Glucocorticoids and synthetic analogues
0.000 0.669 0.331
T42.4 Benzodiazepines
0.000 0.670 0.330
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.674 0.326
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.675 0.325
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.675 0.325
T42.3 Barbiturates
0.000 0.675 0.325
T42.2 Succinimides and oxazolidinediones
0.000 0.675 0.325
T42.0 Hydantoin derivatives
0.000 0.675 0.325
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.679 0.321
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.679 0.320
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.679 0.320
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.679 0.320
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.679 0.320
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.679 0.320
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.679 0.320
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.679 0.320
T44.0 Anticholinesterase agents
0.000 0.679 0.320
T36.9 Systemic antibiotic, unspecified
0.000 0.680 0.320
T36.8 Other systemic antibiotics
0.000 0.680 0.320
T36.7 Antifungal antibiotics, systemically used
0.000 0.680 0.320
T36.6 Rifamycins
0.000 0.680 0.320
T36.5 Aminoglycosides
0.000 0.680 0.320
T36.4 Tetracyclines
0.000 0.680 0.320
T36.3 Macrolides
0.000 0.680 0.320
T36.2 Chloramphenicol group
0.000 0.680 0.320
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.680 0.320
T42.1 Iminostilbenes
0.000 0.695 0.305
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.698 0.301
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.698 0.301
T47.7 Emetics
0.000 0.698 0.301
T47.6 Antidiarrhoeal drugs
0.000 0.698 0.301
T47.5 Digestants
0.000 0.698 0.301
T47.4 Other laxatives
0.000 0.698 0.301
T47.3 Saline and osmotic laxatives
0.000 0.698 0.301
T47.2 Stimulant laxatives
0.000 0.698 0.301
T47.0 Histamine H(2)-receptor antagonists
0.000 0.698 0.301
T45.0 Antiallergic and antiemetic drugs
0.000 0.699 0.301
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.710 0.289
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.712 0.288
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.712 0.288
T37.5 Antiviral drugs
0.000 0.712 0.288
T37.4 Anthelminthics
0.000 0.712 0.288
T37.3 Other antiprotozoal drugs
0.000 0.712 0.288
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.712 0.288
T37.1 Antimycobacterial drugs
0.000 0.712 0.288
T37.0 Sulphonamides
0.000 0.712 0.288
T41.5 Therapeutic gases
0.000 0.712 0.288
T41.4 Anaesthetic, unspecified
0.000 0.712 0.288
T41.3 Local anaesthetics
0.000 0.712 0.288
T41.2 Other and unspecified general anaesthetics
0.000 0.712 0.288
T41.1 Intravenous anaesthetics
0.000 0.712 0.288
T41.0 Inhaled anaesthetics
0.000 0.712 0.288
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.712 0.288
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.712 0.288
T48.5 Anti-common-cold drugs
0.000 0.712 0.288
T48.4 Expectorants
0.000 0.712 0.288
T48.3 Antitussives
0.000 0.712 0.288
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.712 0.288
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.712 0.288
T48.0 Oxytocic drugs
0.000 0.712 0.288
T49.9 Topical agent, unspecified
0.000 0.712 0.288
T49.8 Other topical agents
0.000 0.712 0.288
T49.7 Dental drugs, topically applied
0.000 0.712 0.288
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.712 0.288
T49.5 Ophthalmological drugs and preparations
0.000 0.712 0.288
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.712 0.288
T49.3 Emollients, demulcents and protectants
0.000 0.712 0.288
T49.2 Local astringents and local detergents
0.000 0.712 0.288
T49.1 Antipruritics
0.000 0.712 0.288
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.712 0.288
T40.2 Other opioids
0.000 0.728 0.272
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.731 0.269
T45.8 Other primarily systemic and haematological agents
0.000 0.731 0.269
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.731 0.269
T45.6 Fibrinolysis-affecting drugs
0.000 0.731 0.269
T45.4 Iron and its compounds
0.000 0.731 0.269
T45.3 Enzymes, not elsewhere classified
0.000 0.731 0.269
T45.2 Vitamins, not elsewhere classified
0.000 0.731 0.269
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.745 0.255
T40.8 Lysergide [LSD]
0.000 0.745 0.255
T40.7 Cannabis (derivatives)
0.000 0.745 0.255
T40.5 Cocaine
0.000 0.745 0.255
T40.3 Methadone
0.000 0.745 0.255
T40.1 Heroin
0.000 0.745 0.255
T40.0 Opium
0.000 0.745 0.255
T45.5 Anticoagulants
0.000 0.756 0.244
T40.4 Other synthetic narcotics
0.000 0.757 0.243
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.778 0.222
T40.6 Other and unspecified narcotics
0.000 0.803 0.197
T51.0 Ethanol
0.000 0.938 0.062
T51 Toxic effect of alcohol
0.000 0.972 0.028
E11.4 With neurological complications
0.022 0.978 0.000
T51.8 Other alcohols
0.000 0.979 0.020
T51.3 Fusel oil
0.000 0.979 0.020
T51.2 2-Propanol
0.000 0.979 0.020
T51.1 Methanol
0.000 0.979 0.020
T51.9 Alcohol, unspecified
0.000 0.981 0.019
E11.3 With ophthalmic complications
0.018 0.982 0.000
E11 Non-insulin-dependent diabetes mellitus
0.018 0.982 0.000
E11.2 With renal complications
0.015 0.985 0.000
E11.0 With coma
0.015 0.985 0.000
E11.1 With ketoacidosis
0.014 0.986 0.000
E11.8 With unspecified complications
0.013 0.987 0.000
E11.7 With multiple complications
0.013 0.987 0.000
L71.9 Rosacea, unspecified
0.000 0.989 0.011
E10-E14 Diabetes mellitus
0.011 0.989 0.000
E11.5 With peripheral circulatory complications
0.010 0.990 0.000
Z91.5 Personal history of self-harm
0.000 0.990 0.010
E10 Insulin-dependent diabetes mellitus
0.010 0.990 0.000
E11.6 With other specified complications
0.009 0.991 0.000
E10.4 With neurological complications
0.009 0.991 0.000
E53.8 Deficiency of other specified B group vitamins
0.009 0.991 0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.000 0.991 0.009
E10.2 With renal complications
0.008 0.992 0.000
E10.6 With other specified complications
0.008 0.992 0.000
E10.3 With ophthalmic complications
0.008 0.992 0.000
E12 Malnutrition-related diabetes mellitus
0.008 0.992 0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid
0.000 0.992 0.008
E10.5 With peripheral circulatory complications
0.008 0.992 0.000
E53 Deficiency of other B group vitamins
0.008 0.992 0.000
E10.8 With unspecified complications
0.008 0.992 0.000
I34.0 Mitral (valve) insufficiency
0.008 0.992 0.000
L71 Rosacea
0.000 0.993 0.007
E10.7 With multiple complications
0.007 0.993 0.000
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
0.007 0.993 0.000
T84.2 Mechanical complication of internal fixation device of other bones
0.000 0.993 0.007
T59 Toxic effect of other gases, fumes and vapours
0.000 0.993 0.007
E50-E64 Other nutritional deficiencies
0.007 0.993 0.000
E13 Other specified diabetes mellitus
0.007 0.993 0.000
L71.1 Rhinophyma
0.000 0.993 0.007
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.007 0.993 0.000
T65 Toxic effect of other and unspecified substances
0.000 0.993 0.007
T61 Toxic effect of noxious substances eaten as seafood
0.000 0.993 0.007
T60 Toxic effect of pesticides
0.000 0.993 0.007
T57 Toxic effect of other inorganic substances
0.000 0.993 0.007
T54 Toxic effect of corrosive substances
0.000 0.993 0.007
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone
0.000 0.993 0.007
T52 Toxic effect of organic solvents
0.000 0.993 0.007
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants
0.000 0.993 0.007
T55 Toxic effect of soaps and detergents
0.000 0.993 0.007
C92 Myeloid leukaemia
0.007 0.993 0.000
E10.0 With coma
0.006 0.993 0.000
E55 Vitamin D deficiency
0.006 0.994 0.000
T56 Toxic effect of metals
0.000 0.994 0.006
T58 Toxic effect of carbon monoxide
0.000 0.994 0.006
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.006 0.994 0.000
C92.0 Acute myeloid leukaemia
0.006 0.994 0.000
R07.3 Other chest pain
0.006 0.994 0.000
T62 Toxic effect of other noxious substances eaten as food
0.000 0.994 0.006
E14 Unspecified diabetes mellitus
0.006 0.994 0.000
T63 Toxic effect of contact with venomous animals
0.000 0.994 0.006
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.006 0.994 0.000
E55.9 Vitamin D deficiency, unspecified
0.006 0.994 0.000
C92.9 Myeloid leukaemia, unspecified
0.006 0.994 0.000
E12.9 Without complications
0.006 0.994 0.000
E12.8 With unspecified complications
0.006 0.994 0.000
E12.7 With multiple complications
0.006 0.994 0.000
E12.6 With other specified complications
0.006 0.994 0.000
E12.5 With peripheral circulatory complications
0.006 0.994 0.000
E12.4 With neurological complications
0.006 0.994 0.000
E12.3 With ophthalmic complications
0.006 0.994 0.000
E12.2 With renal complications
0.006 0.994 0.000
E12.1 With ketoacidosis
0.006 0.994 0.000
E12.0 With coma
0.006 0.994 0.000
E46 Unspecified protein-energy malnutrition
0.006 0.994 0.000
E53.1 Pyridoxine deficiency
0.006 0.994 0.000
E53.0 Riboflavin deficiency
0.006 0.994 0.000
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation
0.006 0.994 0.000
E40-E46 Malnutrition
0.006 0.994 0.000
E53.9 Vitamin B deficiency, unspecified
0.006 0.994 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.006 0.994 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.006 0.994 0.000
L71.8 Other rosacea
0.000 0.994 0.005
L71.0 Perioral dermatitis
0.000 0.994 0.005
C91.4 Hairy-cell leukaemia
0.005 0.994 0.000
T59.8 Other specified gases, fumes and vapours
0.000 0.995 0.005
C91 Lymphoid leukaemia
0.005 0.995 0.000
C92.4 Acute promyelocytic leukaemia
0.005 0.995 0.000
C90.2 Plasmacytoma, extramedullary
0.005 0.995 0.000
E14.6 With other specified complications
0.005 0.995 0.000
T59.9 Gases, fumes and vapours, unspecified
0.000 0.995 0.005
T59.7 Carbon dioxide
0.000 0.995 0.005
T59.6 Hydrogen sulphide
0.000 0.995 0.005
T59.5 Fluorine gas and hydrogen fluoride
0.000 0.995 0.005
T59.4 Chlorine gas
0.000 0.995 0.005
T59.3 Lachrymogenic gas
0.000 0.995 0.005
T59.2 Formaldehyde
0.000 0.995 0.005
T59.1 Sulphur dioxide
0.000 0.995 0.005
T59.0 Nitrogen oxides
0.000 0.995 0.005
I12.0 Hypertensive renal disease with renal failure
0.005 0.995 0.000
C92.1 Chronic myeloid leukaemia
0.005 0.995 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.005 0.995 0.000
E63 Other nutritional deficiencies
0.005 0.995 0.000
E56 Other vitamin deficiencies
0.005 0.995 0.000
E51 Thiamine deficiency
0.005 0.995 0.000
E50 Vitamin A deficiency
0.005 0.995 0.000
E60 Dietary zinc deficiency
0.005 0.995 0.000
E59 Dietary selenium deficiency
0.005 0.995 0.000
E58 Dietary calcium deficiency
0.005 0.995 0.000
E54 Ascorbic acid deficiency
0.005 0.995 0.000
E52 Niacin deficiency [pellagra]
0.005 0.995 0.000
E13.8 With unspecified complications
0.005 0.995 0.000
E13.7 With multiple complications
0.005 0.995 0.000
E13.6 With other specified complications
0.005 0.995 0.000
E13.5 With peripheral circulatory complications
0.005 0.995 0.000
E13.4 With neurological complications
0.005 0.995 0.000
E13.3 With ophthalmic complications
0.005 0.995 0.000
E13.2 With renal complications
0.005 0.995 0.000
E13.1 With ketoacidosis
0.005 0.995 0.000
E13.0 With coma
0.005 0.995 0.000
E27.9 Disorder of adrenal gland, unspecified
0.005 0.995 0.000
R93 Abnormal findings on diagnostic imaging of other body structures
0.005 0.995 0.000
T52.9 Organic solvent, unspecified
0.000 0.995 0.005
T52.8 Other organic solvents
0.000 0.995 0.005
T52.4 Ketones
0.000 0.995 0.005
T52.3 Glycols
0.000 0.995 0.005
T52.2 Homologues of benzene
0.000 0.995 0.005
T52.1 Benzene
0.000 0.995 0.005
T52.0 Petroleum products
0.000 0.995 0.005
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified
0.000 0.995 0.005
T53.7 Other halogen derivatives of aromatic hydrocarbons
0.000 0.995 0.005
T53.6 Other halogen derivatives of aliphatic hydrocarbons
0.000 0.995 0.005
T53.5 Chlorofluorocarbons
0.000 0.995 0.005
T53.4 Dichloromethane
0.000 0.995 0.005
T53.3 Tetrachloroethylene
0.000 0.995 0.005
T53.2 Trichloroethylene
0.000 0.995 0.005
T53.1 Chloroform
0.000 0.995 0.005
T53.0 Carbon tetrachloride
0.000 0.995 0.005
T54.9 Corrosive substance, unspecified
0.000 0.995 0.005
T54.3 Corrosive alkalis and alklali-like substances
0.000 0.995 0.005
T54.2 Corrosive acids and acid-like substances
0.000 0.995 0.005
T54.1 Other corrosive organic compounds
0.000 0.995 0.005
T54.0 Phenol and phenol homologues
0.000 0.995 0.005
T57.9 Inorganic substance, unspecified
0.000 0.995 0.005
T57.8 Other specified inorganic substances
0.000 0.995 0.005
T57.3 Hydrogen cyanide
0.000 0.995 0.005
T57.2 Manganese and its compounds
0.000 0.995 0.005
T57.1 Phosphorus and its compounds
0.000 0.995 0.005
T57.0 Arsenic and its compounds
0.000 0.995 0.005
T60.9 Pesticide, unspecified
0.000 0.995 0.005
T60.8 Other pesticides
0.000 0.995 0.005
T60.4 Rodenticides
0.000 0.995 0.005
T60.3 Herbicides and fungicides
0.000 0.995 0.005
T60.2 Other insecticides
0.000 0.995 0.005
T60.1 Halogenated insecticides
0.000 0.995 0.005
T60.0 Organophosphate and carbamate insecticides
0.000 0.995 0.005
T61.9 Toxic effect of unspecified seafood
0.000 0.995 0.005
T61.8 Toxic effect of other seafoods
0.000 0.995 0.005
T61.2 Other fish and shellfish poisoning
0.000 0.995 0.005
T61.1 Scombroid fish poisoning
0.000 0.995 0.005
T61.0 Ciguatera fish poisoning
0.000 0.995 0.005
T65.9 Toxic effect of unspecified substance
0.000 0.995 0.005
T65.8 Toxic effect of other specified substances
0.000 0.995 0.005
T65.6 Paints and dyes, not elsewhere classified
0.000 0.995 0.005
T65.5 Nitroglycerin and other nitric acids and esters
0.000 0.995 0.005
T65.4 Carbon disulphide
0.000 0.995 0.005
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues
0.000 0.995 0.005
T65.2 Tobacco and nicotine
0.000 0.995 0.005
T65.1 Strychnine and its salts
0.000 0.995 0.005
T65.0 Cyanides
0.000 0.995 0.005
C85.1 B-cell lymphoma, unspecified
0.005 0.995 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.005 0.995 0.000
C92.7 Other myeloid leukaemia
0.005 0.995 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.005 0.995 0.000
C92.5 Acute myelomonocytic leukaemia
0.005 0.995 0.000
C92.3 Myeloid sarcoma
0.005 0.995 0.000
C92.2 Subacute myeloid leukaemia
0.005 0.995 0.000
C95 Leukaemia of unspecified cell type
0.005 0.995 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.005 0.995 0.000
E27 Other disorders of adrenal gland
0.005 0.995 0.000
C67.9 Bladder, unspecified
0.005 0.995 0.000
E55.0 Rickets, active
0.005 0.995 0.000
T56.9 Metal, unspecified
0.000 0.995 0.005
T56.7 Beryllium and its compounds
0.000 0.995 0.005
T56.6 Tin and its compounds
0.000 0.995 0.005
T56.5 Zinc and its compounds
0.000 0.995 0.005
T56.4 Copper and its compounds
0.000 0.995 0.005
T56.3 Cadmium and its compounds
0.000 0.995 0.005
T56.2 Chromium and its compounds
0.000 0.995 0.005
T56.1 Mercury and its compounds
0.000 0.995 0.005
T56.0 Lead and its compounds
0.000 0.995 0.005
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract
0.005 0.995 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.005 0.995 0.000
C85.0 Lymphosarcoma
0.005 0.995 0.000
T62.8 Other specified noxious substances eaten as food
0.000 0.995 0.004
T62.2 Other ingested (parts of) plant(s)
0.000 0.995 0.004
T62.1 Ingested berries
0.000 0.995 0.004
T62.0 Ingested mushrooms
0.000 0.995 0.004
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]
0.000 0.995 0.005
E14.8 With unspecified complications
0.005 0.995 0.000
E14.7 With multiple complications
0.005 0.995 0.000
E14.5 With peripheral circulatory complications
0.005 0.995 0.000
E14.4 With neurological complications
0.005 0.995 0.000
E14.2 Withrenal complications
0.005 0.995 0.000
E14.1 With ketoacidosis
0.005 0.995 0.000
E14.0 With coma
0.005 0.995 0.000
T63.9 Toxic effect of contact with unspecified venomous animal
0.000 0.995 0.004
T63.8 Toxic effect of contact with other venomous animals
0.000 0.995 0.004
T63.6 Toxic effect of contact with other marine animals
0.000 0.995 0.004
T63.5 Toxic effect of contact with fish
0.000 0.995 0.004
T63.3 Venom of spider
0.000 0.995 0.004
T63.2 Venom of scorpion
0.000 0.995 0.004
T63.1 Venom of other reptiles
0.000 0.995 0.004
T63.0 Snake venom
0.000 0.995 0.004
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.005 0.995 0.000
C94 Other leukaemias of specified cell type
0.005 0.995 0.000
C93 Monocytic leukaemia
0.005 0.995 0.000
C86 Other specified types of T/NK-cell lymphoma
0.005 0.995 0.000
R93.8 Abnormal findings on diagnostic imaging of other specified body structures
0.005 0.995 0.000
T56.8 Other metals
0.000 0.995 0.004
T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts
0.000 0.995 0.005
C84 Peripheral and cutaneous T-cell lymphomas
0.004 0.995 0.000
C88 Malignant immunoproliferative diseases
0.004 0.996 0.000
C95.0 Acute leukaemia of unspecified cell type
0.004 0.996 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.004 0.996 0.000
E45 Retarded development following protein-energy malnutrition
0.004 0.996 0.000
E43 Unspecified severe protein-energy malnutrition
0.004 0.996 0.000
E42 Marasmic kwashiorkor
0.004 0.996 0.000
E41 Nutritional marasmus
0.004 0.996 0.000
E40 Kwashiorkor
0.004 0.996 0.000
I34 Nonrheumatic mitral valve disorders
0.004 0.996 0.000
E61 Deficiency of other nutrient elements
0.004 0.996 0.000
C90.3 Solitary plasmacytoma
0.004 0.996 0.000
C90.1 Plasma cell leukaemia
0.004 0.996 0.000
C90.0 Multiple myeloma
0.004 0.996 0.000
E27.2 Addisonian crisis
0.004 0.996 0.000
E14.3 With ophthalmic complications
0.004 0.996 0.000
T62.9 Noxious substance eaten as food, unspecified
0.000 0.996 0.004
C91.0 Acute lymphoblastic leukaemia
0.004 0.996 0.000
I34.1 Mitral (valve) prolapse
0.004 0.996 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.004 0.996 0.000
C91.9 Lymphoid leukaemia, unspecified
0.004 0.996 0.000
E20-E35 Disorders of other endocrine glands
0.004 0.996 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.004 0.996 0.000
C91.7 Other lymphoid leukaemia
0.004 0.996 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.004 0.996 0.000
C91.5 Adult T-cell leukaemia
0.004 0.996 0.000
C91.3 Prolymphocytic leukaemia
0.004 0.996 0.000
C91.2 Subacute lymphocytic leukaemia
0.004 0.996 0.000
T63.4 Venom of other arthropods
0.000 0.996 0.004
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.004 0.996 0.000
E27.1 Primary adrenocortical insufficiency
0.004 0.996 0.000
C82.0 Small cleaved cell, follicular
0.004 0.996 0.000
E13.9 Without complications
0.004 0.996 0.000
E10.1 With ketoacidosis
0.004 0.996 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.004 0.996 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.004 0.996 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.004 0.996 0.000
C81 Hodgkin's disease
0.004 0.996 0.000
E50.9 Vitamin A deficiency, unspecified
0.004 0.996 0.000
E50.8 Other manifestations of vitamin A deficiency
0.004 0.996 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.004 0.996 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.004 0.996 0.000
E50.5 Vitamin A deficiency with night blindness
0.004 0.996 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.004 0.996 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.004 0.996 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.004 0.996 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.004 0.996 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.004 0.996 0.000
E51.9 Thiamine deficiency, unspecified
0.004 0.996 0.000
E51.8 Other manifestations of thiamine deficiency
0.004 0.996 0.000
E51.2 Wernicke's encephalopathy
0.004 0.996 0.000
E51.1 Beriberi
0.004 0.996 0.000
E56.9 Vitamin deficiency, unspecified
0.004 0.996 0.000
E56.8 Deficiency of other vitamins
0.004 0.996 0.000
E56.1 Deficiency of vitamin K
0.004 0.996 0.000
E56.0 Deficiency of vitamin E
0.004 0.996 0.000
E63.9 Nutritional deficiency, unspecified
0.004 0.996 0.000
E63.8 Other specified nutritional deficiencies
0.004 0.996 0.000
E63.1 Imbalance of constituents of food intake
0.004 0.996 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.004 0.996 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.004 0.996 0.000
E64.8 Sequelae of other nutritional deficiencies
0.004 0.996 0.000
E64.3 Sequelae of rickets
0.004 0.996 0.000
E64.2 Sequelae of vitamin C deficiency
0.004 0.996 0.000
E64.1 Sequelae of vitamin A deficiency
0.004 0.996 0.000
E64.0 Sequelae of protein-energy malnutrition
0.004 0.996 0.000
R93.6 Abnormal findings on diagnostic imaging of limbs
0.004 0.996 0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract
0.004 0.996 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.004 0.996 0.000
T84 Complications of internal orthopaedic prosthetic devices, implants and grafts
0.000 0.996 0.004
C95.7 Other leukaemia of unspecified cell type
0.004 0.996 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.004 0.996 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.004 0.996 0.000
C84.0 Mycosis fungoides
0.004 0.996 0.000
E27.5 Adrenomedullary hyperfunction
0.004 0.996 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.004 0.996 0.000
E27.0 Other adrenocortical overactivity
0.004 0.996 0.000
C82.6 Cutaneous follicle centre lymphoma
0.004 0.996 0.000
C82.5 Diffuse follicle centre lymphoma
0.004 0.996 0.000
C82.4 Follicular lymphoma grade IIIb
0.004 0.996 0.000
C82.3 Follicular lymphoma grade IIIa
0.004 0.996 0.000
O36.8 Maternal care for other specified foetal problems
0.000 0.996 0.004
E22 Hyperfunction of pituitary gland
0.004 0.996 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.003 0.996 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.003 0.996 0.000
C86.4 Blastic NK-cell lymphoma
0.003 0.996 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.003 0.996 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.003 0.996 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.003 0.996 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.003 0.996 0.000
C93.9 Monocytic leukaemia, unspecified
0.003 0.996 0.000
C93.7 Other monocytic leukaemia
0.003 0.996 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.003 0.996 0.000
C93.2 Subacute monocytic leukaemia
0.003 0.996 0.000
C93.1 Chronic monocytic leukaemia
0.003 0.996 0.000
C93.0 Acute monocytic leukaemia
0.003 0.996 0.000
C94.7 Other specified leukaemias
0.003 0.996 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.003 0.996 0.000
C94.5 Acute myelofibrosis
0.003 0.996 0.000
C94.4 Acute panmyelosis
0.003 0.996 0.000
C94.3 Mast cell leukaemia
0.003 0.996 0.000
C94.2 Acute megakaryoblastic leukaemia
0.003 0.996 0.000
C94.1 Chronic erythraemia
0.003 0.996 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.003 0.996 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.003 0.996 0.000
C96.8 Histiocytic sarcoma
0.003 0.996 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.003 0.996 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.003 0.996 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.003 0.996 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.003 0.996 0.000
C96.3 True histiocytic lymphoma
0.003 0.996 0.000
C96.2 Malignant mast cell tumour
0.003 0.996 0.000
C96.1 Malignant histiocytosis
0.003 0.996 0.000
C96.0 Letterer-Siwe disease
0.003 0.996 0.000
C95.9 Leukaemia, unspecified
0.003 0.996 0.000
E26 Hyperaldosteronism
0.004 0.996 0.000
C82.2 Large cell, follicular
0.003 0.996 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.003 0.996 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.003 0.996 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.003 0.996 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.003 0.996 0.000
C84.3 Lymphoepithelioid lymphoma
0.003 0.996 0.000
C84.2 T-zone lymphoma
0.003 0.996 0.000
C84.1 Sezary's diease
0.003 0.996 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.003 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.